Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M104806200 on June 6, 2001

J. Biol. Chem., Vol. 276, Issue 31, 28731-28738, August 3, 2001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/31/28731    most recent
M104806200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kinoshita, M.
Right arrow Articles by Kaneko, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kinoshita, M.
Right arrow Articles by Kaneko, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Binding of Galpha o N Terminus Is Responsible for the Voltage-resistant Inhibition of alpha 1A (P/Q-type, Cav2.1) Ca2+ Channels*

Mariko KinoshitaDagger , Toshihide Nukada§, Tomiko Asano, Yasuo Mori||, Akinori Akaike**, Masamichi SatohDagger Dagger , and Shuji KanekoDagger §§

From the Departments of Dagger  Neuropharmacology, ** Pharmacology, Dagger Dagger  Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan, the § Department of Neurochemistry, Tokyo Institute of Psychiatry, 2-1-8 Kamikitazawa, Setagaya-ku, Tokyo 156-8585, Japan, the  Department of Biochemistry, Institute for Developmental Research, Aichi Human Service Center, 713-8 Kagiya-cho, Kasugai 480-0392, Japan, and the || Center for Integrative Bioscience and Department of Cell Physiology, National Institute for Physiological Sciences, Okazaki National Research Institutes, Okazaki 444-8585, Japan

G-protein-mediated inhibition of presynaptic voltage-dependent Ca2+ channels is comprised of voltage-dependent and -resistant components. The former is caused by a direct interaction of Ca2+ channel alpha 1 subunits with Gbeta gamma , whereas the latter has not been characterized well. Here, we show that the N terminus of Galpha o is critical for the interaction with the C terminus of the alpha 1A channel subunit, and that the binding induces the voltage-resistant inhibition. An alpha 1A C-terminal peptide, an antiserum raised against Galpha o N terminus, and a Galpha o N-terminal peptide all attenuated the voltage-resistant inhibition of alpha 1A currents. Furthermore, the N terminus of Galpha o bound to the C terminus of alpha 1A in vitro, which was prevented either by the alpha 1A channel C-terminal or Galpha o N-terminal peptide. Although the C-terminal domain of the alpha 1B channel showed similar ability in the binding with Galpha o N terminus, the above mentioned treatments were ineffective in the alpha 1B channel current. These findings demonstrate that the voltage-resistant inhibition of the P/Q-type, alpha 1A channel is caused by the interaction between the C-terminal domain of Ca2+ channel alpha 1A subunit and the N-terminal region of Galpha o.


* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§§ To whom correspondence should be addressed: Dept. of Neuropharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan. Tel./Fax: 81-75-753-4541; E-mail: skaneko@pharm.kyoto-u.ac.jp.


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
H. B. Kordasiewicz, R. M. Thompson, H. B. Clark, and C. M. Gomez
C-termini of P/Q-type Ca2+ channel {alpha}1A subunits translocate to nuclei and promote polyglutamine-mediated toxicity
Hum. Mol. Genet., May 15, 2006; 15(10): 1587 - 1599.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Hardy, G. G. St-Onge, E. Joly, Y. Langelier, and M. Prentki
Oleate Promotes the Proliferation of Breast Cancer Cells via the G Protein-coupled Receptor GPR40
J. Biol. Chem., April 8, 2005; 280(14): 13285 - 13291.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Rousset, T. Cens, A. Gouin-Charnet, F. Scamps, and P. Charnet
Ca2+ and Phosphatidylinositol 4,5-Bisphosphate Stabilize a G{beta}{gamma}-sensitive State of CaV2 Ca2+ Channels
J. Biol. Chem., April 9, 2004; 279(15): 14619 - 14630.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
T. M. Cabrera-Vera, J. Vanhauwe, T. O. Thomas, M. Medkova, A. Preininger, M. R. Mazzoni, and H. E. Hamm
Insights into G Protein Structure, Function, and Regulation
Endocr. Rev., December 1, 2003; 24(6): 765 - 781.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
A. C. Dolphin
G Protein Modulation of Voltage-Gated Calcium Channels
Pharmacol. Rev., December 1, 2003; 55(4): 607 - 627.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
H. L. Agler, J. Evans, H. M. Colecraft, and D. T. Yue
Custom Distinctions in the Interaction of G-protein {beta} Subunits with N-type (CaV2.2) Versus P/Q-type (CaV2.1) Calcium Channels
J. Gen. Physiol., May 27, 2003; 121(6): 495 - 510.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
K. Melliti, M. Grabner, and G. R Seabrook
The familial hemiplegic migraine mutation R192q reduces G-protein-mediated inhibition of p/q-type (Cav2.1) calcium channels expressed in human embryonic kidney cells
J. Physiol., January 15, 2003; 546(2): 337 - 347.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Kanki, M. Kinoshita, A. Akaike, M. Satoh, Y. Mori, and S. Kaneko
Activation of Inositol 1,4,5-Trisphosphate Receptor Is Essential for the Opening of Mouse TRP5 Channels
Mol. Pharmacol., November 1, 2001; 60(5): 989 - 998.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement